Compounded tirzepatide contains the same active ingredient as Mounjaro, but its dosage and some ingredients may differ from ...

Participants were randomly assigned either to escalation of dulaglutide to 4.5 mg or maximum tolerated dose (MTD), or to ...

Tirzepatide, a dual glucose-dependent insulinotropic polypeptide, or GIP, and glucagon-like peptide-1, or GLP-1, receptor ...

Tirzepatide linked to more GI issues than semaglutide in new study on weight-loss drugs without diabetes. Read more!

Researchers sought to determine 1-year outcomes in patients being treated with tirzepatide who have atrial fibrillation.

Disparities in prescribing semaglutide and tirzepatide for obesity reveal social factors affecting access and highlight the ...

Tirzepatide's uptake was rapid post-launch, surpassing other GLP-1 RAs and SGLT2 inhibitors, while conventional GLMs like metformin and insulin declined. The approval of tirzepatide for type 2 ...

As the popularity of peptides continues to rise in 2025, fueled by the success of GLP-1 medications like Semaglutide and Tirzepatide, more individuals are exploring their potential health benefits ...

Tirzepatide mimics two key hormones in your body, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Both hormones play essential roles after eating ...

Eli Lilly then spurred it on further with tirzepatide — a GLP-1RA and gastric inhibitory polypeptide (GIP) agonist. Tirzepatide is sold under the brand names Mounjaro and Zepbound for T2D ...

outperforming established peptides like Tirzepatide and Liraglutide (Ma et al., 2025). Furthermore, Retatrutide showed promising effects in reducing diabetic nephropathy markers, inflammation ...

Tirzepatide, a dual glucose-dependent insulinotropic polypeptide, or GIP, and glucagon-like peptide-1, or GLP-1, receptor agonist, has shown promise in promoting weight loss and improving ...